Reviva Pharmaceuticals Files 8-K
Ticker: RVPH · Form: 8-K · Filed: Jun 2, 2025
Sentiment: neutral
Topics: 8-K, corporate-filing, disclosure
TL;DR
Reviva Pharma dropped an 8-K on 6/2, check it for Reg FD, other events, and financials.
AI Summary
Reviva Pharmaceuticals Holdings, Inc. filed an 8-K on June 2, 2025, reporting on various events. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company, formerly known as Tenzing Acquisition Corp., is incorporated in Delaware and headquartered in Cupertino, CA.
Why It Matters
This 8-K filing provides an update on Reviva Pharmaceuticals' corporate activities, including regulatory disclosures and financial information, which are important for investors to monitor the company's status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting on standard corporate events and disclosures, not indicating any immediate significant risks.
Key Numbers
- 001-38634 — SEC File Number (Identifies the company's filing with the SEC.)
- 85-4306526 — IRS Employer Identification No. (Tax identification number for the company.)
Key Players & Entities
- REVIVA PHARMACEUTICALS HOLDINGS, INC. (company) — Registrant
- Tenzing Acquisition Corp. (company) — Former company name
- June 2, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Cupertino, CA (location) — Principal executive offices address
FAQ
What specific events are disclosed under 'Other Events' in this 8-K?
The provided text does not detail the specific 'Other Events' but lists it as an item reported.
What is the significance of the 'Regulation FD Disclosure' item?
Regulation FD (Fair Disclosure) requires public companies to disclose material non-public information to the public in a broad and non-exclusionary manner.
When did Reviva Pharmaceuticals Holdings, Inc. change its name from Tenzing Acquisition Corp.?
The date of the name change was June 6, 2018.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
What is the business address of Reviva Pharmaceuticals Holdings, Inc.?
The business address is 10080 N. Wolfe Rd., Suite SW3-200, Cupertino, CA 95014.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH).